PMS: Do All Women Get It, and What Actually Helps

PMS gets used casually to explain a wide range of cyclical experiences, from mild bloating to significant mood shifts. That breadth of usage has blurred an important distinction: feeling different before your period is almost universal, but clinically significant premenstrual syndrome is not. Understanding what PMS actually is, what causes it, and what the evidence says about treatment is more useful than either dismissing it or assuming every premenstrual symptom counts as a disorder.

What PMS actually is

Premenstrual syndrome has a clinical definition. It describes a pattern of physical and psychological symptoms that occur during the luteal phase of the menstrual cycle, typically in the one to two weeks before menstruation, and that resolve within a few days of the period starting. The symptom-free window is part of the definition: PMS symptoms cycle with the menstrual cycle. If symptoms persist year-round without clearing after the period begins, another explanation is more likely.

The physical symptoms associated with PMS include bloating, breast tenderness, headaches, fatigue, and changes in appetite. The psychological symptoms include irritability, low mood, anxiety, difficulty concentrating, and emotional sensitivity. To meet the clinical threshold for PMS, symptoms must be severe enough to interfere with daily activities and must be confirmed across at least two consecutive cycles, ideally by prospective tracking rather than retrospective recall.

This prospective tracking requirement exists for a reason. Research has consistently shown that retrospective reports of premenstrual symptoms tend to overestimate both their frequency and severity compared to symptoms recorded in real time. The cultural expectation that people become difficult before their period creates a recall bias that inflates the apparent prevalence of PMS when people are asked to remember what they felt rather than record it as it happens.

How common is it

A 2014 epidemiological review by Direkvand-Moghadam and colleagues, published in the Journal of Clinical and Diagnostic Research, pooled data across multiple studies and found that premenstrual symptoms of some kind affect the majority of menstruating people. Mild cyclical changes are genuinely common. Clinical-severity PMS, where symptoms are severe enough to disrupt work, relationships, or daily functioning, affects approximately 20 to 30 per cent of menstruating people.

At the severe end of the spectrum, premenstrual dysphoric disorder, or PMDD, affects an estimated 3 to 8 per cent. PMDD is distinguished from PMS by the severity of its psychological component, particularly marked depressive symptoms, severe anxiety, or intense irritability that significantly impairs functioning. PMDD is a recognised clinical diagnosis and is treated differently from standard PMS.

What this means practically is that a wide range of experiences gets called PMS. Someone noticing mild breast tenderness in the week before their period and someone experiencing severe depression and inability to function for ten days each month are both using the same term. The distinction matters because the appropriate response is different, and because conflating mild cyclical symptoms with clinical PMS contributes to both overdiagnosis and undertreatment.

The hormonal mechanism

PMS is not caused by abnormally high or low hormone levels. People with PMS typically have hormone levels within the normal range. What appears to differ is sensitivity to the hormonal changes that occur naturally in the luteal phase, when progesterone rises after ovulation and both oestrogen and progesterone fall in the days before menstruation.

Yonkers and colleagues, in their 2008 Lancet review, outlined the prevailing understanding of the mechanism: progesterone is metabolised into allopregnanolone, a neurosteroid that modulates GABA receptors in the brain. In most people this has a calming, anxiolytic effect. In people with PMS, the brain's GABA receptors appear to respond differently to allopregnanolone, producing anxiety, irritability, or mood disruption rather than the usual stabilising effect.

The serotonin system is also implicated. Serotonin levels fluctuate across the menstrual cycle, and research suggests that people with PMS and PMDD show greater serotonergic sensitivity to luteal-phase changes. This is why SSRIs, which increase serotonin availability, are effective treatments for severe PMS and PMDD, and why they work even when taken only during the luteal phase rather than continuously. The target is serotonin dysregulation in response to normal hormonal shifts, not the hormonal shifts themselves.

Physical symptoms explained

Bloating before a period is largely driven by two mechanisms. Oestrogen promotes water and sodium retention, and progesterone affects gut motility, slowing digestion and contributing to the full, uncomfortable feeling in the abdomen. The bloating is real and has a physiological basis; it is not imagined and it is not weight gain, despite feeling like it.

Breast tenderness, or mastalgia, in the premenstrual phase is caused by hormonal stimulation of glandular breast tissue. Oestrogen and progesterone both promote fluid retention in breast tissue, and the cyclic increase in progesterone during the luteal phase is the primary driver. Breast tenderness that follows a clear cyclical pattern and resolves with menstruation is benign and very common.

Headaches in the premenstrual phase are associated with the drop in oestrogen that occurs in the late luteal phase. Oestrogen withdrawal affects serotonin pathways and vascular tone, both of which are relevant to migraine and tension headache mechanisms. People with a history of migraine often find their attacks are more frequent or severe in the days before their period, a pattern sometimes called menstrual migraine.

Fatigue in the luteal phase has multiple contributors. Progesterone has sedating properties. Sleep architecture can shift in this phase. And the elevated basal body temperature that persists through the luteal phase (about 0.2 to 0.5 degrees Celsius higher than the follicular phase) may contribute to a sense of heaviness and reduced energy.

Psychological symptoms

Irritability and emotional sensitivity in the premenstrual phase are the symptoms most commonly reported and most frequently used to dismiss people's emotional responses as cyclical rather than legitimate. The research is clear that these symptoms are real and physiologically driven, not character flaws or poor emotional regulation.

The mechanism connects to both the GABA and serotonin systems described earlier. When serotonin availability drops in the late luteal phase, emotional regulation becomes harder. The prefrontal cortex, which moderates emotional responses, relies partly on serotonergic signalling. When that signalling is disrupted, the threshold for experiencing frustration, sadness, or anxiety shifts downward. Things that would not normally provoke a strong reaction do so more readily, not because something is wrong with your judgment, but because the neurochemical system that ordinarily buffers emotional responses is temporarily less effective.

Low mood and anxiety in the luteal phase follow the same pathway. The fall in oestrogen in the late luteal phase reduces serotonin synthesis and increases the activity of the monoamine oxidase enzyme that breaks serotonin down, effectively lowering the floor of available serotonin precisely when the GABA system's response to allopregnanolone may also be dysregulated.

Brain fog, reported as difficulty concentrating or word-finding problems before a period, is less well characterised in the literature but is consistent with the neurochemical changes described above. Serotonin and oestrogen both play roles in memory consolidation and attentional focus. Cyclical dips in both may contribute to the subjective sense of cognitive blunting.

What actually helps

Regular aerobic exercise has the strongest evidence base among lifestyle interventions for PMS. Multiple studies have found that consistent moderate-intensity exercise across the full menstrual cycle reduces both physical and psychological PMS symptoms. The mechanism likely involves exercise's effects on serotonin, endorphin release, and the reduction of prostaglandin-driven cramping and inflammation. Exercise in the luteal phase specifically may help, but the evidence is stronger for consistent exercise as a habit rather than strategic luteal-phase exercise alone.

Calcium supplementation has consistent support across several randomised controlled trials. A dosage of 1000 to 1200 mg of elemental calcium per day has been shown to reduce mood and physical PMS symptoms significantly compared to placebo. The mechanism is not fully established but likely involves calcium's role in neurotransmitter function and its interaction with vitamin D and parathyroid hormone, both of which fluctuate across the menstrual cycle.

Dietary changes with reasonable evidence include reducing salt intake to limit water retention and bloating, reducing caffeine (which can worsen anxiety, breast tenderness, and headaches), and limiting alcohol, which disrupts serotonin metabolism and worsens mood symptoms. These changes are most relevant in the luteal phase, though a generally lower intake year-round tends to produce more consistent results.

For severe PMS and PMDD, SSRIs are the most evidence-supported pharmacological treatment. Dickerson and colleagues' 2003 review in American Family Physician confirmed that SSRIs, taken either continuously or only during the luteal phase, produce significant symptom reduction in severe PMS and PMDD. This is a treatment to discuss with a doctor, not to self-administer, but it is a legitimate and well-supported option rather than a last resort.

What does not reliably help

Evening primrose oil is frequently marketed for PMS. The evidence for it is weak. Clinical trials have not produced consistent results, and systematic reviews have not supported its use for PMS symptoms beyond a possible modest effect on breast tenderness in some individuals. It is not harmful to try, but the claims made for it substantially exceed what the research supports.

Vitamin B6 alone similarly has an inconsistent evidence base. Some early trials showed benefit, but methodological limitations and inconsistency across studies mean it cannot be confidently recommended as a standalone PMS treatment. It may have a modest role as part of a broader nutritional approach, but the supplement industry's marketing around B6 and PMS runs ahead of the science.

Many other supplements are sold specifically for premenstrual symptoms. The majority have not been tested in adequately powered randomised controlled trials, and those that have been tested often fail to outperform placebo. This is not a reason to dismiss symptom management entirely; it is a reason to focus on the interventions with actual evidence rather than spending money on those without it.

PMDD: when to see a doctor

PMDD is distinguished from PMS by the severity and nature of its psychological symptoms. Where PMS involves mood changes that are noticeable and uncomfortable, PMDD involves mood disruption severe enough to impair daily functioning: inability to work, severe relationship conflict, profound hopelessness, intense anxiety, or in some cases suicidal ideation. These are clinical symptoms that require clinical attention.

Diagnosis requires prospective symptom tracking over at least two cycles, ruling out other conditions that might explain the symptoms, and confirming the cyclical pattern. It is worth seeing a gynaecologist or psychiatrist with experience in reproductive mental health rather than a general practitioner who may be less familiar with the diagnostic criteria and treatment options.

Effective treatments for PMDD include SSRIs (first line), oral contraceptives containing drospirenone, and in refractory cases, GnRH agonists that suppress ovulation. Each of these has a different mechanism and different side-effect profile. The appropriate choice depends on whether contraception is also wanted, how severe the symptoms are, and individual health history. The point is that PMDD is treatable, and if what you experience each cycle significantly disrupts your life for one to two weeks, that is worth addressing with proper medical support.

If you have grown up being told PMS is just drama, as many women in India are, the science is a useful corrective: real premenstrual symptoms are common and physiological, and there are things that genuinely help.